![](/img/cover-not-exists.png)
Clinical significance of circulating CD33+CD11b+HLA-DR- myeloid cells in Stage-IV melanoma patients treated with ipilimumab
Sade-Feldman, M., Kanterman, J., Klieger, Y., Ish-Shalom, E., Mizrahi, O., Saragovi, A., Shtainberg, H., Lotem, M., Baniyash, M.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-3104
Date:
May, 2016
File:
PDF, 1.09 MB
english, 2016